Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Damage | 12 | 2025 | 356 | 2.420 |
Why?
|
| DNA, Mitochondrial | 8 | 2025 | 191 | 1.940 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 7 | 2025 | 19 | 1.710 |
Why?
|
| DNA Repair | 11 | 2025 | 198 | 1.330 |
Why?
|
| Azoxymethane | 2 | 2025 | 9 | 1.090 |
Why?
|
| Liver | 3 | 2025 | 511 | 0.770 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2009 | 199 | 0.740 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2009 | 110 | 0.620 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2014 | 247 | 0.480 |
Why?
|
| DNA Repair Enzymes | 3 | 2009 | 22 | 0.360 |
Why?
|
| Endodeoxyribonucleases | 3 | 2009 | 28 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 218 | 0.350 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 512 | 0.340 |
Why?
|
| DNA, Fungal | 3 | 2009 | 49 | 0.330 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 2019 | 8 | 0.310 |
Why?
|
| Electron Transport | 1 | 2019 | 47 | 0.300 |
Why?
|
| Ultraviolet Rays | 4 | 2004 | 118 | 0.250 |
Why?
|
| Mice | 9 | 2025 | 6644 | 0.240 |
Why?
|
| Fungal Proteins | 3 | 2002 | 142 | 0.220 |
Why?
|
| Mitochondria | 3 | 2014 | 523 | 0.210 |
Why?
|
| DNA Replication | 4 | 2004 | 148 | 0.200 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 83 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 1869 | 0.180 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2004 | 47 | 0.180 |
Why?
|
| Animals | 10 | 2025 | 16992 | 0.170 |
Why?
|
| Huntington Disease | 2 | 2012 | 31 | 0.160 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 183 | 0.160 |
Why?
|
| Gene Deletion | 3 | 2009 | 168 | 0.150 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 665 | 0.140 |
Why?
|
| DNA Polymerase III | 1 | 1997 | 9 | 0.140 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 16 | 0.130 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 532 | 0.130 |
Why?
|
| Ligases | 1 | 1996 | 8 | 0.130 |
Why?
|
| Male | 7 | 2025 | 23409 | 0.120 |
Why?
|
| Carcinogens | 1 | 2017 | 126 | 0.120 |
Why?
|
| Enzyme Activators | 1 | 2015 | 11 | 0.110 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 14 | 0.110 |
Why?
|
| Cyclophilins | 1 | 2015 | 12 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2015 | 42 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2019 | 90 | 0.100 |
Why?
|
| Metformin | 1 | 2015 | 75 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1596 | 0.100 |
Why?
|
| DNA | 3 | 2011 | 592 | 0.100 |
Why?
|
| Mitochondria, Heart | 2 | 2019 | 60 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 203 | 0.090 |
Why?
|
| Neostriatum | 1 | 2012 | 28 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 455 | 0.090 |
Why?
|
| Epistasis, Genetic | 3 | 2004 | 19 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 291 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2015 | 1003 | 0.090 |
Why?
|
| Antioxidants | 1 | 2015 | 443 | 0.090 |
Why?
|
| Spermatogenesis | 1 | 2011 | 161 | 0.080 |
Why?
|
| Cell Line | 2 | 2019 | 1410 | 0.080 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2002 | 18 | 0.080 |
Why?
|
| Carbon-Oxygen Lyases | 2 | 2000 | 4 | 0.080 |
Why?
|
| Spermatozoa | 1 | 2011 | 214 | 0.080 |
Why?
|
| Electron Transport Complex I | 1 | 2019 | 29 | 0.080 |
Why?
|
| Alkylation | 1 | 2009 | 11 | 0.080 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 41 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 189 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1997 | 186 | 0.070 |
Why?
|
| Kinetics | 1 | 2009 | 695 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2011 | 91 | 0.060 |
Why?
|
| Rats | 2 | 2019 | 3735 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 2004 | 23 | 0.060 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 561 | 0.060 |
Why?
|
| alpha-Fetoproteins | 3 | 1995 | 32 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2012 | 383 | 0.060 |
Why?
|
| Endonucleases | 1 | 2004 | 18 | 0.050 |
Why?
|
| Humans | 6 | 2017 | 43102 | 0.050 |
Why?
|
| SUMO-1 Protein | 1 | 2004 | 16 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2004 | 81 | 0.050 |
Why?
|
| Deoxyribonuclease IV (Phage T4-Induced) | 2 | 2000 | 2 | 0.050 |
Why?
|
| Templates, Genetic | 1 | 2002 | 23 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 39 | 0.050 |
Why?
|
| Middle Aged | 2 | 2014 | 12222 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 168 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2002 | 48 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2004 | 15 | 0.040 |
Why?
|
| Aged | 1 | 2014 | 8214 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 91 | 0.040 |
Why?
|
| Mutation | 4 | 2012 | 1177 | 0.040 |
Why?
|
| Methyl Methanesulfonate | 1 | 2000 | 6 | 0.040 |
Why?
|
| Alkylating Agents | 1 | 2000 | 14 | 0.040 |
Why?
|
| Mutagens | 1 | 2000 | 74 | 0.040 |
Why?
|
| Plasmids | 2 | 1996 | 244 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 190 | 0.030 |
Why?
|
| Female | 3 | 2014 | 24698 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 1996 | 12 | 0.030 |
Why?
|
| G2 Phase | 1 | 1996 | 28 | 0.030 |
Why?
|
| S Phase | 1 | 1996 | 36 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 1995 | 2 | 0.030 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1995 | 4 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 1995 | 4 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1995 | 34 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1542 | 0.030 |
Why?
|
| Pyrones | 1 | 2015 | 11 | 0.030 |
Why?
|
| Tyrosine | 1 | 1995 | 120 | 0.030 |
Why?
|
| Oxidants | 1 | 2015 | 42 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 53 | 0.030 |
Why?
|
| Thiophenes | 1 | 2015 | 32 | 0.030 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 1994 | 91 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 278 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 462 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 159 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 458 | 0.020 |
Why?
|
| Gene Expression | 2 | 2012 | 701 | 0.020 |
Why?
|
| Autopsy | 1 | 2012 | 48 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 64 | 0.020 |
Why?
|
| Base Sequence | 3 | 2004 | 983 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1124 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 719 | 0.020 |
Why?
|
| Heterozygote | 1 | 2011 | 110 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1082 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1285 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 457 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 281 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 386 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1857 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 27 | 0.020 |
Why?
|
| Guanosine | 1 | 2008 | 28 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2008 | 34 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1009 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1154 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 306 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3156 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 2157 | 0.010 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2004 | 4 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 2004 | 8 | 0.010 |
Why?
|
| Glycolates | 1 | 2004 | 6 | 0.010 |
Why?
|
| Transglutaminases | 1 | 2004 | 7 | 0.010 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2004 | 14 | 0.010 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2004 | 2 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 2004 | 33 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 1568 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 22 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 712 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1994 | 1621 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1995 | 1271 | 0.010 |
Why?
|
| Genes, rev | 1 | 1998 | 2 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 13872 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1180 | 0.010 |
Why?
|
| Heptanoates | 1 | 1995 | 1 | 0.010 |
Why?
|
| Hydrolases | 1 | 1995 | 15 | 0.010 |
Why?
|
| Pancreas | 1 | 1995 | 45 | 0.010 |
Why?
|
| Amino Acids | 1 | 1995 | 148 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1994 | 80 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1994 | 55 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1994 | 148 | 0.010 |
Why?
|
| Fetus | 1 | 1994 | 101 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 508 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1994 | 352 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1995 | 224 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 16 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1992 | 26 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1994 | 456 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1994 | 526 | 0.010 |
Why?
|
| Transfection | 1 | 1992 | 532 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1992 | 333 | 0.000 |
Why?
|
| Kidney | 1 | 1992 | 372 | 0.000 |
Why?
|
| Transcription Factors | 1 | 1992 | 735 | 0.000 |
Why?
|
| Brain | 1 | 1992 | 1472 | 0.000 |
Why?
|